Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

Apr 29, 2020

BUY
$46.4 - $67.43 $1,113 - $1,618
24 Added 4.17%
599 $544,000
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $253,754 - $300,862
-5,933 Reduced 91.16%
575 $640,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $359,176 - $405,123
6,508 New
6,508 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Financial Advocates Investment Management Portfolio

Follow Financial Advocates Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.